C12Y 304/22017
Calpain
Official title: Calpain (3.4.22.17) (C12Y304/22052, C12Y304/22053 take precedence)
C12Y304/22017 (Calpain) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 4
- Assignees
- 3
- Inventors
- 6
- Latest grant
- 19 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Polypeptide having effect of inhibiting proliferation of leukemia cells13 Mar 2025US 2025/0084138 A1Nanjing Fengrui Biotechnology Co., Ltd
- Methods for modulating cancer cells and stem cells6 Apr 2017US 2017/0095524 A1The Scripps Research Institute
- Methods and Compositions for Neuroprotection15 Dec 2016US 2016/0362695 A1Quark Pharmaceuticals, Inc.
- Methods and compositions for neuroprotection29 Jan 2015US 2015/0031746 A1Quark Pharmaceuticals, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.